Quotient Successfully Emerges from Chapter 11 Process and Completes Refinancing Plan
• Raised $51 million of new capital and reduced debt by approximately $140 million
• Company to refocus commercial effort on Alba and expand MosaiQ into autoimmune and allergy
• Company to refocus commercial effort on Alba and expand MosaiQ into autoimmune and allergy
Quotient Limited Announces Reverse Stock Split Effective Today
JERSEY, Channel Islands, November 2, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company"), a commercial-stage diagnostics company, today announced that a reverse split of its ordinary shares, nil par value ("Ordinary Shares"), at a ratio of 1-for-40 became…
Quotient Limited Announces Intent to Effect Reverse Stock Split
JERSEY, Channel Islands, October 31, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company"), a commercial-stage diagnostics company, today announced that it will effect a one-for-40 reverse stock split ("Reverse Stock Split") of its ordinary shares, nil par…
Quotient Limited Selected to Join the World Economic Forum New Champions Community
• The World Economic Forum’s New Champions Community brings together purpose driven companies of mid-size whose leadership is mindful of their impact on society and aspiring in building a better future
• These companies champion new business models and technologies to build…
• These companies champion new business models and technologies to build…
Quotient Limited Expands MosaiQ Innovator’s Circle to Empower Patient Care and Laboratory Efficiencies
• The National Screening Laboratory of Sanquin Blood Supply Foundation joins MosaiQ Innovator’s Circle
Quotient Limited Provides First Quarter Fiscal 2023 Results and Business Update
JERSEY, Channel Islands, August 9, 2022 (GLOBE NEWSWIRE) – Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today reported its first quarter fiscal 2023 key financial results and provided an update on recent…
Quotient Limited to Report First Quarter Fiscal 2023 Financial Results and Host Conference Call on August 9th
Quotient Limited and InfYnity Biomarkers Announce Partnership to Expand MosaiQ Infectious Disease Menu
- Partnership aims to expand the Transfusion Transmissible Infections, other Infectious Diseases, and clinical diagnostics assay menu on Quotient’s multimodality, multiplexed MosaiQ solution